It is not approved by the FDA, EMA, or comparable regulators as a drug for treating androgenetic alopecia, telogen effluvium, or any other hair-loss condition
Your healthcare provider depends on consistent medication quality to evaluate your actual response
There's no competition
In one study, GLP-1s were found to act directly on skin cells, potentially worsening facial thinning beyond fat loss alone
Metabolic and bariatric surgery versus intensive non-surgical treatment for adolescents with severe obesity (AMOS2): a multicentre, randomised, controlled trial in Sweden
Extensive scientific research has demonstrated its ability to promote tissue regeneration, accelerate wound healing, reduce inflammation and promote gut health